Moving Forward With Biologics in Lupus Nephritis.
Sign Up to like & getrecommendations! Published in 2019 at "Advances in chronic kidney disease"
DOI: 10.1053/j.ackd.2019.08.008
Abstract: The majority of patients with systemic lupus erythematosus develop lupus nephritis (LN) which significantly contributes to increased risks of hospitalizations, ESRD, and death. Unfortunately, treatments for LN have not changed over the past 15 years. Despite… read more here.
Keywords: moving forward; lupus nephritis; biologics lupus; forward biologics ... See more keywords